annual EBITDA:
-$167.17M-$74.97M(-81.31%)Summary
- As of today (July 1, 2025), VERA annual EBITDA is -$167.17 million, with the most recent change of -$74.97 million (-81.31%) on December 31, 2024.
- During the last 3 years, VERA annual EBITDA has fallen by -$134.76 million (-415.77%).
- VERA annual EBITDA is now -1380.30% below its all-time high of -$11.29 million, reached on December 31, 2019.
Performance
VERA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$49.82M-$8.32M(-20.05%)Summary
- As of today (July 1, 2025), VERA quarterly EBITDA is -$49.82 million, with the most recent change of -$8.32 million (-20.05%) on March 31, 2025.
- Over the past year, VERA quarterly EBITDA has dropped by -$23.35 million (-88.23%).
- VERA quarterly EBITDA is now -2027.11% below its all-time high of -$2.34 million, reached on March 31, 2020.
Performance
VERA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$167.77M-$23.35M(-16.17%)Summary
- As of today (July 1, 2025), VERA TTM EBITDA is -$167.77 million, with the most recent change of -$23.35 million (-16.17%) on March 31, 2025.
- Over the past year, VERA TTM EBITDA has dropped by -$78.82 million (-88.62%).
- VERA TTM EBITDA is now -7063.45% below its all-time high of -$2.34 million, reached on March 31, 2020.
Performance
VERA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VERA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.3% | -88.2% | -88.6% |
| 3 y3 years | -415.8% | -193.8% | -275.4% |
| 5 y5 years | -1380.3% | -2027.1% | -2807.1% |
VERA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -415.8% | at low | -238.3% | at low | -199.4% | at low |
| 5 y | 5-year | -1380.3% | at low | -1370.8% | at low | -2807.1% | at low |
| alltime | all time | -1380.3% | at low | -2027.1% | at low | -7063.4% | at low |
VERA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$49.82M(+20.0%) | -$167.77M(+16.2%) |
| Dec 2024 | -$167.17M(+81.3%) | -$41.50M(-7.1%) | -$144.42M(+13.3%) |
| Sep 2024 | - | -$44.67M(+40.6%) | -$127.51M(+25.0%) |
| Jun 2024 | - | -$31.78M(+20.1%) | -$102.00M(+14.7%) |
| Mar 2024 | - | -$26.47M(+7.6%) | -$88.95M(-3.0%) |
| Dec 2023 | -$92.20M(+4.7%) | -$24.59M(+28.4%) | -$91.67M(-7.3%) |
| Sep 2023 | - | -$19.16M(+2.3%) | -$98.92M(-5.2%) |
| Jun 2023 | - | -$18.73M(-35.8%) | -$104.30M(+4.0%) |
| Mar 2023 | - | -$29.20M(-8.3%) | -$100.29M(+13.9%) |
| Dec 2022 | -$88.06M | -$31.84M(+29.8%) | -$88.05M(+20.6%) |
| Sep 2022 | - | -$24.53M(+66.6%) | -$73.01M(+30.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$14.72M(-13.2%) | -$56.03M(+25.4%) |
| Mar 2022 | - | -$16.96M(+1.0%) | -$44.69M(+37.9%) |
| Dec 2021 | -$32.41M(-38.8%) | -$16.79M(+122.4%) | -$32.41M(-44.6%) |
| Sep 2021 | - | -$7.55M(+123.0%) | -$58.48M(+7.0%) |
| Jun 2021 | - | -$3.39M(-27.6%) | -$54.65M(-0.1%) |
| Mar 2021 | - | -$4.68M(-89.1%) | -$54.69M(+4.5%) |
| Dec 2020 | -$52.99M(+369.3%) | - | - |
| Dec 2020 | - | -$42.86M(+1051.2%) | -$52.35M(+451.4%) |
| Sep 2020 | - | -$3.72M(+8.6%) | -$9.49M(+64.5%) |
| Jun 2020 | - | -$3.43M(+46.4%) | -$5.77M(+146.4%) |
| Mar 2020 | - | -$2.34M | -$2.34M |
| Dec 2019 | -$11.29M | - | - |
FAQ
- What is Vera Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Vera Therapeutics?
- What is Vera Therapeutics annual EBITDA year-on-year change?
- What is Vera Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vera Therapeutics?
- What is Vera Therapeutics quarterly EBITDA year-on-year change?
- What is Vera Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Vera Therapeutics?
- What is Vera Therapeutics TTM EBITDA year-on-year change?
What is Vera Therapeutics annual EBITDA?
The current annual EBITDA of VERA is -$167.17M
What is the all time high annual EBITDA for Vera Therapeutics?
Vera Therapeutics all-time high annual EBITDA is -$11.29M
What is Vera Therapeutics annual EBITDA year-on-year change?
Over the past year, VERA annual EBITDA has changed by -$74.97M (-81.31%)
What is Vera Therapeutics quarterly EBITDA?
The current quarterly EBITDA of VERA is -$49.82M
What is the all time high quarterly EBITDA for Vera Therapeutics?
Vera Therapeutics all-time high quarterly EBITDA is -$2.34M
What is Vera Therapeutics quarterly EBITDA year-on-year change?
Over the past year, VERA quarterly EBITDA has changed by -$23.35M (-88.23%)
What is Vera Therapeutics TTM EBITDA?
The current TTM EBITDA of VERA is -$167.77M
What is the all time high TTM EBITDA for Vera Therapeutics?
Vera Therapeutics all-time high TTM EBITDA is -$2.34M
What is Vera Therapeutics TTM EBITDA year-on-year change?
Over the past year, VERA TTM EBITDA has changed by -$78.82M (-88.62%)